Lymph node dissection in patients with differentiated thyroid carcinoma - who benefits?

被引:37
作者
Mann, B [1 ]
Buhr, HJ [1 ]
机构
[1] Free Univ Berlin, Klinikum Benjamin Franklin, Klin Allgemein Gefass & Thoraxchirurg, D-12200 Berlin, Germany
关键词
differentiated thyroid carcinoma; lymph node metastases; prognostic factors; surgical treatment;
D O I
10.1007/s004230050148
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Papillary and follicular thyroid carcinomas are the most common thyroid malignancies and are usually indolent. Lymph-node involvement increases the rate of tumor recurrence and reduces long-term survival. However, characteristics such as age, long-term iodine deficiency, histological grade, extrathyroidal extension and distant metastases are clearly much more potent adverse factors than cervical lymph node metastases. Although there are no prospective randomised studies showing the overall benefit of routine cervicocentral lymphnode dissection in addition to total thyroidectomy, we propose this procedure as a standard part of primary surgery in differentiated thyroid carcinoma (DTC). Results: In specialised centres, morbidity is not higher than for thyroidectomy alone. However, there is a significant increase in morbidity after re-operation in the cervicocentral compartment. Modified neck dissection of the cervicolateral compartment should only be performed if there is clinical evidence of lymph-node involvement in this area. Conclusions: This strategy provides the optimal surgical treatment for all subgroups of patients with DTC and creates optimal conditions for effective postoperative radioiodine ablation, which is another prognostic factor strongly associated with recurrence and survival in these patients.
引用
收藏
页码:355 / 358
页数:4
相关论文
共 26 条
[1]  
Cady B, 1981, World J Surg, V5, P3
[2]   PROGNOSTIC FACTORS AND MANAGEMENT CONSIDERATIONS IN PATIENTS WITH CERVICAL METASTASES OF THYROID-CANCER [J].
COBURN, MC ;
WANEBO, HJ .
AMERICAN JOURNAL OF SURGERY, 1992, 164 (06) :671-676
[3]   DOES THE METHOD OF MANAGEMENT OF PAPILLARY THYROID-CARCINOMA MAKE A DIFFERENCE IN OUTCOME [J].
DEGROOT, LJ ;
KAPLAN, EL ;
STRAUS, FH ;
SHUKLA, MS .
WORLD JOURNAL OF SURGERY, 1994, 18 (01) :123-130
[4]   Lymphadenectomy in thyroid cancer [J].
Dralle, H ;
Gimm, O .
CHIRURG, 1996, 67 (08) :788-806
[5]  
Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO
[6]  
2-0
[7]   MUTATIONAL ACTIVATION OF RAS AND GSP ONCOGENES IN DIFFERENTIATED THYROID-CANCER AND THEIR BIOLOGICAL IMPLICATIONS [J].
GORETZKI, PE ;
LYONS, J ;
STACYPHIPPS, S ;
ROSENAU, W ;
DEMEURE, M ;
CLARK, OH ;
MCCORMICK, F ;
ROHER, HD ;
BOURNE, HR .
WORLD JOURNAL OF SURGERY, 1992, 16 (04) :576-582
[8]  
HARNESS JK, 1992, WORLD J SURG, V16, P437
[9]  
Hughes CJ, 1996, HEAD NECK-J SCI SPEC, V18, P127, DOI 10.1002/(SICI)1097-0347(199603/04)18:2<127::AID-HED3>3.0.CO
[10]  
2-3